Article
Next-generation sequencing-based multigene mutational screening for acute myeloid leukemia using MiSeq: applicability for diagnostics and disease monitoring.
Haematologica - 1 Mar 2014
Luthra Rajyalakshmi, Patel Keyur P, Reddy Neelima G, Haghshenas Varan, Routbort Mark J, Harmon Michael A, Barkoh Bedia A, Kanagal-Shamanna Rashmi, Ravandi Farhad, Cortes Jorge E, Kantarjian Hagop M, Medeiros L Jeffrey, Singh Rajesh R
Abstract excerpt
Routine molecular testing in acute myeloid leukemia involves screening several genes of therapeutic and prognostic significance for mutations. A comprehensive analysis using single-gene assays requires large amounts of DNA, is cumbersome and timely consolidation of results for clinical reporting is challenging. High throughput, next-generation sequencing platforms widely used in research have not been tested...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
